News & Updates

Clascoterone cream holds promise as alternative to traditional acne treatments

21 Jul 2020 by

Treatment with clascoterone cream 1% results in a favourable safety profile, with a low frequency of treatment-emergent adverse events (TEAEs) over 9 months, in patients with acne vulgaris, results of a recent study have shown.

Clascoterone cream holds promise as alternative to traditional acne treatments

21 Jul 2020

Two phase III trials support clinical benefit of anifrolumab in SLE

15 Jul 2020 by

The type I interferon receptor antibody anifrolumab reduced disease activity and flares in patients with moderate-to-severe active systemic lupus erythematosus (SLE), results of the TULIP-1 and TULIP-2 trials have shown.

Two phase III trials support clinical benefit of anifrolumab in SLE

15 Jul 2020

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

08 Jul 2020 by

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

08 Jul 2020

Biologics show promise in treatment of erythrodermic psoriasis

06 Jul 2020

Use of biologic medications to treat erythrodermic psoriasis (EP) is well-tolerated by and induces positive responses in patients, with a weak recommendation and limited quality of evidence in favour of infliximab, ustekinumab, ixekizumab, and guselkumab, a recent study has shown.

Biologics show promise in treatment of erythrodermic psoriasis

06 Jul 2020

Cell therapy with autologous DSC may help treat hair loss

06 Jul 2020

Autologous cell-based therapy using dermal sheath cup (DSC) appears to have beneficial effects for the treatment of male (MPHL) and female pattern hair loss (FPHL), suggest the results of a study.

Cell therapy with autologous DSC may help treat hair loss

06 Jul 2020

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment

05 Jul 2020

A recent study has assessed the long-term safety of nine systemic medications for psoriasis, revealing the lowest incidence of adverse events with ustekinumab and secukinumab.

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment

05 Jul 2020

Best biologics for psoriasis? Meta-analysis suggests three

30 Jun 2020 by

Brodalumab, risankizumab, and ixekizumab rank as the top three best performing biologic drugs for psoriasis, yielding the highest rates of complete clearance of lesions and scoring a high probability of being the most effective in the induction treatment phase, according to the results of a network meta-analysis.

Best biologics for psoriasis? Meta-analysis suggests three

30 Jun 2020

Oral minoxidil proven safe, effective for treating alopecia

29 Jun 2020

Use of low-dose oral minoxidil is safe and effective in the treatment of androgenic alopecia and alopecia areata, in addition to demonstrating a big advantage over the topical formulation in terms of convenience and patient compliance, as reported in a systematic review.

Oral minoxidil proven safe, effective for treating alopecia

29 Jun 2020

Voriconazole tied to increased SCC risk in lung transplant recipients

26 Jun 2020 by

Exposure to voriconazole is associated with increased risk of cutaneous squamous cell carcinoma (SCC) in lung transplant recipients, especially after prolonged exposure, a US study suggests.

Voriconazole tied to increased SCC risk in lung transplant recipients

26 Jun 2020

Adjuvant dabrafenib plus trametinib prolongs RFS in stage III melanoma

22 Jun 2020 by

Adjuvant treatment with dabrafenib plus trametinib prolongs relapse-free survival (RFS) in patients with resected stage III BRAF V600-mutant melanoma, according to a 5-year analysis of the COMBI-AD* study presented at the ASCO20 Virtual Scientific Program.

Adjuvant dabrafenib plus trametinib prolongs RFS in stage III melanoma

22 Jun 2020

News & Updates

Filter by Specialty:

Specialty:

Clascoterone cream holds promise as alternative to traditional acne treatments

Clascoterone cream holds promise as alternative to traditional acne treatments

Two phase III trials support clinical benefit of anifrolumab in SLE

Two phase III trials support clinical benefit of anifrolumab in SLE

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

Biologics show promise in treatment of erythrodermic psoriasis

Biologics show promise in treatment of erythrodermic psoriasis

Cell therapy with autologous DSC may help treat hair loss

Cell therapy with autologous DSC may help treat hair loss

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment

Best biologics for psoriasis? Meta-analysis suggests three

Best biologics for psoriasis? Meta-analysis suggests three

Oral minoxidil proven safe, effective for treating alopecia

Oral minoxidil proven safe, effective for treating alopecia

Voriconazole tied to increased SCC risk in lung transplant recipients

Voriconazole tied to increased SCC risk in lung transplant recipients

Adjuvant dabrafenib plus trametinib prolongs RFS in stage III melanoma

Adjuvant dabrafenib plus trametinib prolongs RFS in stage III melanoma